{"id":197314,"name":"BIOMARIN PHARMACEUTICAL INC.","slug":"biomarin-pharmaceutical-inc","state":"CA","country":"United States of America","description":"","totalSpending":9620000,"filings":32,"yearlySpending":[{"year":2018,"income":820000},{"year":2019,"income":1070000},{"year":2020,"income":1360000},{"year":2021,"income":1040000},{"year":2022,"income":1370000},{"year":2023,"income":1320000},{"year":2024,"income":1320000},{"year":2025,"income":1320000}],"issues":["HCR","MMM","TRD","IMM","BUD","TAX","TAR"],"firms":["BIOMARIN PHARMACEUTICAL INC."],"lobbyists":["JOHN GREISSING","KATHRYN LOWELL","TERICKE BLANCHARD"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Homeland Security, Dept of (DHS)","U.S. Immigration & Customs Enforcement (ICE)","Health & Human Services, Dept of (HHS)","Centers For Medicare and Medicaid Services (CMS)","Government Accountability Office (GAO)","Commerce, Dept of (DOC)","Executive Office of the President (EOP)","Food & Drug Administration (FDA)"],"sampleDescriptions":["H.R. 5247: TRICKETT WENDLER, FRANK MONGIELLO, JORDAN MCLINN, AND MATTHEW BELLINA RIGHT TO TRY ACT OF 2018; ALL PROVISIONS OF THE BILL\n\nS. 204: TRICKETT WENDLER, FRANK MONGIELLO, JORDAN MCLINN, AND MAT","GENERAL DISCUSSIONS REGARDING MEDICAID OUT OF STATE PROVIDERS, MEDICAID 1115 WAIVERS AND PRIOR AUTHORIZATION AND MEDICARE PART B AND D COVERAGE OF RARE DISEASE THERAPIES","H.R. 5247: TRICKETT WENDLER, FRANK MONGIELLO, JORDAN MCLINN, AND MATTHEW BELLINA RIGHT TO TRY ACT OF 2018; ALL PROVISIONS OF THE BILL\n\nH.R. 5115: RARE dISEASE ADVANCEMENT, RESEARCH, AND EDUCATION (RAR","H.R. 6801: RARE DISEASE FUND (RaD) ACT OF 2018; ALL PROVISION OF THE BILL\n\nGENERAL DISCUSSIONS REGARDING GENE THERAPY\n\nGENERAL DISCUSSIONS REGARDING PHENYLKETONURIA(PKU) EDUCATION AND OUTREACH\n\nGENERA","H.R. 3325: ACE KIDS ACT; ALL PROVISIONS OF THE BILL\n\nH.R. 6505: MEDICARE NEGOTIATION AND COMPETITIVE LICENSING ACT OF 2018; ALL PROVISIONS OF THE BILL\n\nH.R. 6524: ACCELERATING KIDS' ACCESS TO CARE ACT"],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}